stockrowGinkgo Bioworks Holdings, Inc. (DNA) vs Sana Biotechnology, Inc. (SANA)
- Ginkgo Bioworks Holdings, Inc. DNA 11.19 +12.35%
- Sana Biotechnology, Inc. SANA 2.37 +1.28%
Ginkgo Bioworks Holdings, Inc. and Sana Biotechnology, Inc. are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and Sana Biotechnology, Inc. are of similar size ($700.5M and $670.7M). Sana Biotechnology, Inc. has the higher net margin (0.00% vs −260.0%) and the higher return on invested capital (0.00% vs −161.9%). Across the 13 metrics below, Sana Biotechnology, Inc. leads on 7 and Ginkgo Bioworks Holdings, Inc. on 6.
Valuation
Profitability
| Metric | DNA | SANA | Biotechnology median |
|---|---|---|---|
| Gross margin | 80.55% | 0.00% | 68.51% |
| Operating margin | (273.61%) | 0.00% | 0.00% |
| Net margin | (259.96%) | 0.00% | 0.00% |
| Free cash flow margin | (155.75%) | 0.00% | 0.00% |
| Return on equity | (56.29%) | (152.87%) | (51.96%) |
| Return on assets | (26.19%) | (53.41%) | (46.06%) |
| Return on invested capital | (161.94%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack